background image

The Globe and Mail

Former cannabis executives betting psychedelic drugs could be the next big thing

Former cannabis executives betting psychedelic drugs could be the next big thing

“There’s a lot of untapped value in psychedelic substances because they’re [illegal],” said JR Rahn, founder of Toronto-based MindMed, which counts Canopy founder Bruce Linton and Shark Tank star Kevin O’Leary among its early investors.

arrow
Download PDF

Former cannabis executives betting psychedelic drugs could be the next big thing